Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Filings indexed 1,617 across all filing types
Latest filing 2022-08-09 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
111年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all reported as zero. The content is concise, factual, and does not contain detailed financial statements or analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or vote. Given the short length (601 characters) and the nature of the data, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-09 Chinese
111年7月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a summarized financial data report showing monthly and cumulative net operating revenue figures for a company named 景岳, with comparisons to the previous year and explanations for changes. It is very short (787 characters) and contains no detailed financial statements or analysis, only key financial figures and notes. It does not present a full annual or interim report, nor is it an announcement of a meeting or voting results. It is a brief factsheet style summary of financial data. Therefore, it fits best into the Fund Information / Factsheet (FS) category, which covers brief summaries of key company financials and market info.
2022-08-09 Chinese
公告本公司111年第二季合併財務報告提報董事會
Interim / Quarterly Report Classification · 95% confidence The document is a financial announcement from company 3164 景岳, dated 111/08/08 (Taiwan calendar year 111 corresponds to 2022). It reports the submission of the company's consolidated financial report for the second quarter (January 1 to June 30) to the board of directors and audit committee approval on the same date. The document includes cumulative financial figures such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity as of the period end. The document length is 887 characters, which is relatively short but contains substantive financial data for a half-year period. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements or substantive financial data and analysis for a period shorter than a full fiscal year. It is not merely an announcement of report publication but includes key financial figures. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2022
2022-08-08 Chinese
111年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, chairman, general manager, and other executives. It lists their share types, holdings at different times, increases and decreases in shares, and related notes. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is about 9509 characters, which is sufficient for a detailed insider shareholding report. Therefore, the classification is DIRS with high confidence.
2022-08-04 Chinese
111年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and management. It lists individual holdings, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This type of disclosure aligns with insider share transactions or holdings reporting. Given the nature of the data—personal shareholdings by directors and executives—it fits best under the category of Director's Dealing (DIRS). The document length is short and contains no financial statements or report announcements, so it is not a report or announcement. Therefore, the classification is DIRS with high confidence.
2022-08-04 Chinese
111年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not present a full report but rather a regulatory disclosure of specific financial data points. There is no indication of an annual or interim report, audit report, or other detailed filings. Given the nature and length, this fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.